Among the silenced genes was BCL11A, whose overexpression is observed in many hematological cancers and mediates its oncogenic role in leukemia via target genes Bcl2, Bcl2-xL, Mdm2, and p53 [47,48]. This evidence concerns the gene BCL11A and hematopoietic and lymphoid cell neoplasm.